Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer-Reference-Cited by-同舟云学术

Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer

Published:2020-02-19 Issue:4 Volume:111 Page:1375-1384
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Lin Po‐Han¹²^ORCID,Chen Ming¹³,Tsai Li‐Wei⁴,Lo Chiao⁴,Yen Tzu‐Chun¹,Huang Thomas Yoyan¹,Chen Chih‐Kai¹,Fan Sheng‐Chih¹,Kuo Sung‐Hsin⁵,Huang Chiun‐Sheng⁴⁶

Affiliation:

1. Department of Medical Genetics National Taiwan University Hospital Taipei Taiwan

2. Institute of Medical Genomics and Proteomics College of Medicine National Taiwan University Taipei Taiwan

3. Department of Genomic Medicine and Center for Medical Genetics Changhua Christian Hospital Changhua Taiwan

4. Department of Surgery National Taiwan University Hospital Taipei Taiwan

5. Department of Medical Oncology National Taiwan University Hospital Taipei Taiwan

6. Department of Surgery College of Medicine National Taiwan University Taipei Taiwan

Funder

National Taiwan University Hospital

Ministry of Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14313

Reference50 articles.

1. Triple negative breast cancer: looking for the missing link between biology and treatments

2. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

3. Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin

4. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

5. Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer;2024-07-18

2. Exploring the Potential of Nanomolecular Therapeutic Therapy Options, and Novel Biomarkers in Triple-negative Breast Cancer Treatment;Current Cancer Therapy Reviews;2024-06-11

3. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing;Pathology - Research and Practice;2024-02

4. A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations;Diagnostic Pathology;2024-01-06

5. The Role of Genetic Data Analysis for Precision Therapy in Cancer;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29